Table A1.
Item | Definition |
---|---|
Population of interest | Adults aged 60 years or older having received at least one dose of any respiratory syncytial virus vaccine |
Exposure | Exposed to RSV infection during the subsequent RSV season |
Control/comparator | Adults aged 60 years or older not vaccinated against respiratory syncytial virus (placebo) |
Outcome | Occurrence of lower respiratory tract disease and/or acute respiratory infection |